Log In
BCIQ
Print this Print this
 

Liquid iCALM (PUR003)

  Manage Alerts
Collapse Summary General Information
Company Pulmatrix Inc.
DescriptionInhaled cationic airway lining modulator (iCALM)
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationAsthma
Indication DetailsTreat asthma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/16/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today